• Follow
  • Follow
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise

Log in

Start free trial
G2 Intelligence
  • Reports
    • Lab Industry Advisor
      • Essentials Reports
      • Premium Reports
      • Elite Reports
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Articles
    • Lab Industry Advisor
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Webinars
  • Store
  • Reports
    • Lab Industry Advisor
      • Essentials Reports
      • Premium Reports
      • Elite Reports
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Articles
    • Lab Industry Advisor
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Webinars
  • Store
CDC Calls Continued Rise in Cases of STIs “Alarming”

CDC Calls Continued Rise in Cases of STIs “Alarming”

by Miriam Bergeret, MSc | May 5, 2023 | Clinical Diagnostics Insider, Diagnostic Testing and Emerging Technologies, Testing Trends-dtet

Health inequities and disrupted STI testing and care during the pandemic continued to contribute to a rise in cases in 2021.

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
The Diagnostics Pipeline: FDA Unveils Plan to End COVID-19 Test Emergency Use Authorizations

The Diagnostics Pipeline: FDA Unveils Plan to End COVID-19 Test Emergency Use Authorizations

by Glenn S. Demby | Apr 24, 2023 | Clinical Diagnostics Insider, Diagnostic Testing and Emerging Technologies, FDA-dtet

On March 27, the agency released a new guidance document to help test developers make the transition to full approval.

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
Senators to HHS: Keep Covering At-Home COVID-19 Tests After PHE Ends

Senators to HHS: Keep Covering At-Home COVID-19 Tests After PHE Ends

by Glenn S. Demby | Apr 17, 2023 | News, Open Content

Group of 18 senators says ending Medicare coverage for at-home COVID-19 tests would undo efforts to contain spread of the coronavirus.

Medical Device Executives Nailed with Fraud Charges

Medical Device Executives Nailed with Fraud Charges

by Rachel Muenz | Apr 12, 2023 | News, Open Content

The three Magellan Diagnostics executives are accused of FDA violations, as well as wire fraud and conspiracy.

Early in Pandemic, HIV Testing Dropped Sharply, but Quickly Rebounded

by Glenn S. Demby | Jan 26, 2023 | Clinical Diagnostics Insider, Diagnostic Testing and Emerging Technologies, Testing Trends-dtet

A recent CDC report concludes that disruptions to HIV testing due to the COVID-19 pandemic compromised America’s ability to prevent the disease.

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
« Older Entries
Next Entries »

Sign up for our free weekly Lab & Pathology Insider email newsletter

Log In

Join Now | Lost Password?
  • Follow
  • Follow
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
Copyright © 2025 G2Intelligence.com